Company Filing History:
Years Active: 2022-2025
Title: Qiang Cheng: Innovator in mRNA Delivery Technologies
Introduction
Qiang Cheng is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of mRNA delivery technologies. With a total of 10 patents, Cheng has made remarkable advancements that have the potential to revolutionize therapeutic approaches for various diseases.
Latest Patents
Cheng's latest patents include innovative lipid nanoparticle compositions designed for the effective delivery of mRNA and long nucleic acids. One of his notable inventions focuses on lipid nanoparticles that utilize a cationic ionizable lipid, a phospholipid, a PEGylated lipid, and a steroid. This composition is particularly effective for delivering large RNAs, including mRNAs, and aims to treat diseases where mRNA delivery is therapeutically beneficial. Another significant patent involves compositions and methods for organ-specific delivery of nucleic acids, which demonstrate preferential targeting to specific organs. This invention comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid, enhancing the delivery of nucleic acids.
Career Highlights
Cheng is affiliated with the University of Texas System, where he continues to push the boundaries of research in the field of biotechnology. His work has garnered attention for its potential applications in medicine and therapeutic interventions.
Collaborations
Cheng collaborates with esteemed colleagues, including Daniel J Siegwart and Tuo Wei, who contribute to his research endeavors and innovations in the field.
Conclusion
Qiang Cheng's work in mRNA delivery technologies exemplifies the innovative spirit of modern science. His patents and research have the potential to significantly impact therapeutic strategies, paving the way for future advancements in medicine.